Back
Novo Nordisk AS Stock Price Chart

Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
20
NVO
Novo Nordisk AS
Last Price:
$65.75
Seasonality Move:
4.73%
7 Day Trial
ALL ACCESS PASS
$
7

The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing selling pressure, which indicates risk of future bearish movement.
Novo Nordisk AS Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 66.86 | Sell |
20-day SMA: | 64.16 | Buy |
50-day SMA: | 70.89 | Sell |
200-day SMA: | 99.94 | Sell |
8-day EMA: | 66 | Sell |
20-day EMA: | 65.78 | Sell |
50-day EMA: | 70.42 | Sell |
200-day EMA: | 91.94 | Sell |
Novo Nordisk AS Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.73 | Sell |
Relative Strength Index (14 RSI): | 48.32 | Sell |
Chaikin Money Flow: | -9408596 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (61.01 - 66.77) | Buy |
Bollinger Bands (100): | (67.53 - 90.39) | Sell |
Novo Nordisk AS Technical Analysis
Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
28 | 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Novo Nordisk AS Stock
Is Novo Nordisk AS Stock a Buy?
-
Novo Nordisk AS share price is 65.77 while NVO 8-day simple moving average is 66.86, which is a Sell signal.
-
The stock price of NVO is 65.77 while Novo Nordisk AS 20-day SMA is 64.16, which makes it a Buy.
-
Novo Nordisk AS 50-day simple moving average is 70.89 while NVO share price is 65.77, making it a Sell technically.
-
NVO stock price is 65.77 and Novo Nordisk AS 200-day simple moving average is 99.94, creating a Sell signal.
NVO Technical Analysis vs Fundamental Analysis
Sell
20
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy or a Sell?
-
Novo Nordisk AS stock is rated a SellThe current Novo Nordisk AS [NVO] share price is $65.77. The Score for NVO is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
Novo Nordisk AS Stock Info
Market Cap:
292.2B
Price in USD:
65.77
Share Volume:
11.7M
Novo Nordisk AS 52-Week Range
52-Week High:
148.15
52-Week Low:
57.00
Sell
20
Novo Nordisk AS (NVO)
is a Sell
Novo Nordisk AS Share Price Forecast
-
What is the Novo Nordisk AS stock price today?The Novo Nordisk AS stock price is 65.77 USD today.
-
Will NVO stock go up or go down?Novo Nordisk AS> share price is forecast to RISE/FALL based on technical indicators
-
Is Novo Nordisk AS overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Novo Nordisk AS is overvalued.
Is Novo Nordisk AS Stock a Buy?
-
Novo Nordisk AS share price is 65.77 while NVO 8-day exponential moving average is 66.00, which is a Sell signal.
-
The stock price of NVO is 65.77 while Novo Nordisk AS 20-day EMA is 65.78, which makes it a Sell.
-
Novo Nordisk AS 50-day exponential moving average is 70.42 while NVO share price is 65.77, making it a Sell technically.
-
NVO stock price is 65.77 and Novo Nordisk AS 200-day simple moving average is 91.94, creating a Sell signal.
Fundamental Analysis of Novo Nordisk AS
Is Novo Nordisk AS a good investment?
-
Analysts estimate an earnings increase this quarter of $0.28 per share, an increase next quarter of $0.11 per share, an increase this year of $0.92 per share, and an increase next year of $0.78 per share.
Technical Analysis of Novo Nordisk AS
Should I short Novo Nordisk AS stock?
-
NVO Moving Average Covergence Divergence (MACD) indicator is -0.73, suggesting Novo Nordisk AS is a Sell
-
Novo Nordisk AS Relative Strength Index (RSI) is 48.32, which suggest Novo Nordisk AS is oversold
-
The Bollinger Bands (25) for Novo Nordisk AS is (61.01 - 66.77), which suggest Novo Nordisk AS is a Sell
-
The Bollinger Bands (100) for Novo Nordisk AS is (67.53 - 90.39), which suggest Novo Nordisk AS is a Sell
* Novo Nordisk AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.